Cargando…
Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779262/ https://www.ncbi.nlm.nih.gov/pubmed/33408017 http://dx.doi.org/10.1016/j.ijantimicag.2020.106172 |
| _version_ | 1783631296803635200 |
|---|---|
| author | Parra-Lara, Luis Gabriel Martinez-Arboleda, Juan José Isaza-Pierotti, Daniel Francisco Rosso, Fernando |
| author_facet | Parra-Lara, Luis Gabriel Martinez-Arboleda, Juan José Isaza-Pierotti, Daniel Francisco Rosso, Fernando |
| author_sort | Parra-Lara, Luis Gabriel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7779262 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd and International Society of Antimicrobial Chemotherapy. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77792622021-01-04 Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial Parra-Lara, Luis Gabriel Martinez-Arboleda, Juan José Isaza-Pierotti, Daniel Francisco Rosso, Fernando Int J Antimicrob Agents Letter to the Editor Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021-01 2021-01-04 /pmc/articles/PMC7779262/ /pubmed/33408017 http://dx.doi.org/10.1016/j.ijantimicag.2020.106172 Text en © 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Parra-Lara, Luis Gabriel Martinez-Arboleda, Juan José Isaza-Pierotti, Daniel Francisco Rosso, Fernando Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial |
| title | Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial |
| title_full | Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial |
| title_fullStr | Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial |
| title_full_unstemmed | Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial |
| title_short | Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial |
| title_sort | effect estimation of hydroxychloroquine for covid-19: a secondary analysis of an open label non-randomized clinical trial |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779262/ https://www.ncbi.nlm.nih.gov/pubmed/33408017 http://dx.doi.org/10.1016/j.ijantimicag.2020.106172 |
| work_keys_str_mv | AT parralaraluisgabriel effectestimationofhydroxychloroquineforcovid19asecondaryanalysisofanopenlabelnonrandomizedclinicaltrial AT martinezarboledajuanjose effectestimationofhydroxychloroquineforcovid19asecondaryanalysisofanopenlabelnonrandomizedclinicaltrial AT isazapierottidanielfrancisco effectestimationofhydroxychloroquineforcovid19asecondaryanalysisofanopenlabelnonrandomizedclinicaltrial AT rossofernando effectestimationofhydroxychloroquineforcovid19asecondaryanalysisofanopenlabelnonrandomizedclinicaltrial |